About
More answers from less tissue.
ViewsML uses deep learning for virtual staining, predicting biomarker expression and spatial localization at the per-cell level from routine H&E images, without consuming additional tissue.
Mission
Tissue is finite, but the information it holds is extensive. Our mission is to draw more of that information from routine H&E slides through virtual staining, so researchers and pathologists can explore biomarker expression while preserving tissue for downstream testing.
How we work
We are a multidisciplinary team spanning data science, software engineering, machine learning, and clinical expertise. We work independently and collaborate across sales, research, and product.
leadership
Built by pathologists, engineers, and operators.
Kenneth To, PhD, MBA
CHIEF EXECUTIVE OFFICER
Eli Lilly & Co. · Stemcell Technologies ·
Wax-it Histology Services (co-founder)
Serial entrepreneur with expertise in medical affairs, marketing, and product management.
Keith Jalbert, BBA
CHIEF COMMERCIAL OFFICER
Synnex · Baxter · Novartis
Sales strategy and execution. Previously responsible for growing a $300M business to $1.6B across 120 sales representatives.
Christopher Jackson, MD, MEng
CHIEF SCIENTIFIC OFFICER
Massachusetts General Hospital · Dartmouth Hitchcock Medical Center
Co-inventor of virtual IHC technology, clinical pathologist, and AI computer scientist.
George Hennen, MBA, CISM
CHIEF TECHNOLOGY OFFICER
Oracle · Cisco · GE Healthcare · NASA
R&D strategy, product development, cybersecurity, and AI.
Rafay Azhar, MD, FRCPath (UK)
MEDICAL DIRECTOR
University of Ottawa · Singapore General Hospital ·
Freeman Hospital Newcastle upon Tyne, UK
Anatomical pathologist with 20+ years of experience in diagnostic pathology, digital pathology, and providing clinical and scientific guidance.